Qube Research & Technologies LTD Adamis Pharmaceuticals Corp Transaction History

Qube Research & Technologies LTD

5 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q2 2021 Aug 13, 2021	SELL	$0.66 - $1.23 $21,392 - $39,867	-32,413 Closed	0 $0
Q1 2021 May 14, 2021	SELL	$0.54 - $1.79 $74,565 - $247,172	-138,085 Reduced 80.99%	32,413 $30,000
Q4 2020 Feb 16, 2021	SELL	$0.4 - $1.01 $139,426 - $352,050	-348,565 Reduced 67.15%	170,498 $83,000
Q3 2020 Nov 12, 2020	BUY	$0.52 - $1.45 $225,560 - $628,967	433,771 Added 508.57%	519,063 $407,000
Q2 2020 Aug 14, 2020	BUY	$0.33 - $0.66 $28,146 - $56,292	85,292 New	85,292 $46,000

Ticker ADMP
Exchange NASDAQ
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 149,983,008
Market Cap $73.5M
Description
Adamis Pharmaceuticals Corporation, a specialty biopharmaceutical company, develops and commercializes products in the therapeutic areas of allergy, opioid overdose, respiratory, and inflammatory disease in the United States. The company's product candidates comprise SYMJEPI epinephrine pre-filled syringe injectable products for use in the emerg...

Get notified when there are updates to the investment portfolio of Qube Research & Technologies LTD, based on Form 13F filings with the SEC.

Stay updated on Qube Research & Technologies LTD with notifications on news.